Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Janz, Martin Dr. (4) Lusatis, Simone (1) Mathas, Stephan Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (10) (-) Leisegang, Matthias Prof. Dr. rer. nat. (1) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (10) Proteom Dynamik (2) (-) 1992 (4) 1993 (7) (-) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (3) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (7) 2020 (1) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Leisegang, Matthias Prof. Dr. rer. nat.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 199219942006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein 01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein 01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein 01. November 1992 / J Immunol Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity S. Ehlers M.E. Mielke T. Blankenstein H. Hahn 01. Januar 1992 / Immunology Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression H. Rothe I. Schuller G. Richter C.V. Jongeneel U. Kiesel T. Diamantstein T. Blankenstein H. Kolb 01. Januar 1992 / Eur J Immunol Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction C. Platzer G. Richter K. Ueberla W. Mueller H. Bloecker T. Diamantstein T. Blankenstein 01. Januar 1992 / Eur J Immunol Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma C. Platzer G. Richter K. Ueberla H. Hock T. Diamantstein T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Januar 1994 / Folia Biol Observations with tumour necrosis factor gene-transfected tumours T. Blankenstein
01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
01. Januar 1994 / Nat Immun Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy H. Hock M. Dorsch G. Richter U. Kunzendorf S. Krueger-Krasagakes T. Blankenstein Z.H. Qin T. Diamantstein
01. November 1992 / J Immunol Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity S. Ehlers M.E. Mielke T. Blankenstein H. Hahn
01. Januar 1992 / Immunology Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression H. Rothe I. Schuller G. Richter C.V. Jongeneel U. Kiesel T. Diamantstein T. Blankenstein H. Kolb
01. Januar 1992 / Eur J Immunol Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction C. Platzer G. Richter K. Ueberla W. Mueller H. Bloecker T. Diamantstein T. Blankenstein
01. Januar 1992 / Eur J Immunol Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma C. Platzer G. Richter K. Ueberla H. Hock T. Diamantstein T. Blankenstein